CALITHERA BIOSCIENCES, INC.

Analyst Reco. Calithera Biosciences, Inc.

Equities

CALA

US13089P5070

Market Closed - OTC Markets Other stock markets 09:30:40 2024-04-26 am EDT			5-day change	1st Jan Change
0.02 ^USD	0.00%		-31.03%	-33.33%

2023	Calithera Biosciences, Inc. Launches the Cala kIQ System, Offering Meaningful Tremor Relief for Patients with Essential Tremor and Now Parkinson’s Disease	CI
2023	North American Morning Briefing : Stock Futures -2-	DJ

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ladenburg Thalmann Downgrades Calithera Biosciences to Neutral From Buy	22-11-15	MT
SVB Securities Downgrades Calithera Biosciences to Market Perform From Outperform, Adjusts Price Target to $2 From $18	22-11-15	MT
HC Wainwright Upgrades Calithera Biosciences to Buy From Neutral; Price Target is $8	22-08-29	MT
SVB Leerink Adjusts Calithera Biosciences' Price Target to $2 from $3, Keeps Outperform Rating	22-04-04	MT
Ladenburg Thalmann Starts Calithera Biosciences at Buy with $4 Price Target	22-01-31	MT
SVB Leerink Upgrades Calithera Biosciences to Outperform From Market Perform, Price Target at $3	22-01-20	MT
HC Wainwright Downgrades Calithera Biosciences to Neutral From Buy	21-11-08	MT
Wells Fargo Downgrades Calithera Biosciences to Equal Weight From Overweight, Adjusts PT to $3 From $10	21-11-05	MT
CALITHERA BIOSCIENCES : HC Wainwright Adjusts Price Target on Calithera Biosciences to $4 From $9.50, Reiterates Buy Rating	21-01-05	MT
CALITHERA BIOSCIENCES : SVB Leerink Downgrades Calithera Biosciences to Market Perform From Outperform; Price Target is $2	21-01-05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer